🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07582029
Starting soon Not applicable

Ultrasound-Guided Rectus Sheath Block Versus Local Infiltration

NCT07582029 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-12
Last updated
2026-05-12

Condition(s) studied

CholelithiasesCholecystitisPostoperative Pain

Investigational drug(s) / intervention(s)

Rectus Sheath BlockLocal Anesthetic Infiltration

Rectus Sheath Block: After completion of the operation, during the surgical closure phase, bilateral rectus sheath block will be performed. A linear ultrasound probe will be placed transversely over the umbilicus and 1 cm lateral to it. After visualization of the rectus abdominis muscle and posterior rectus sheath, a 22-Gauge 80 mm block needle (Braun Stimuplex Ultra-360, Melsungen, Germany) will be advanced from lateral to medial using the in-plane technique. Following hydrodissection with 1 mL saline between the rectus muscle and posterior sheath and confirmation of appropriate spread, 20 mL local anesthetic (0.25% bupivacaine) will be administered with intermittent negative aspiration.

Local Anesthetic Infiltration: At the end of the operation, the surgeon will infiltrate 5 mL local anesthetic (0.5% bupivacaine) subcutaneously into each of the four trocar insertion sites.

Study summary

Laparoscopic cholecystectomy is associated with significant postoperative pain originating from trocar sites, pneumoperitoneum, and visceral irritation. Both local anesthetic infiltration and ultrasound-guided rectus sheath block are commonly used regional analgesic techniques to reduce postoperative pain and opioid consumption. This prospective randomized controlled study aims to compare the effects of these two techniques on postoperative pain scores, opioid requirements, and analgesia-related adverse effects following laparoscopic cholecystectomy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ASA (American Society of Anesthesiologists) class I-II patients * Patients aged between 18 and 65 years * Patients undergoing laparoscopic cholecystectomy surgery Exclusion Criteria: * ASA class III-IV patients * Patients undergoing emergency surgery * Relatives of patients who do not provide consent * Presence of chronic pain * Chronic opioid use * Presence of local anesthetic allergy * Ibuprofen allergy * Paracetamol allergy * Presence of infection at the block site * Coagulopathy * Increased intracranial pressure * Pre-existing neurological deficit * Severe organ failure * Mental retardation * Anatomical deformity

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sisli Hamidiye Etfal Training Hospital Istanbul Turkey (Türkiye)

More Sisli Hamidiye Etfal Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07582029 on ClinicalTrials.gov ↗ ← All trials in Turkey